Status:
COMPLETED
24 Hour IOP Lowering Efficacy of AL-3789
Lead Sponsor:
Alcon Research
Conditions:
Open-angle Glaucoma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The objective of this study was to describe the intraocular pressure-lowering efficacy of AL-3789 over a 24-hour period in patients with open-angle glaucoma compared to an untreated control. Patients ...
Eligibility Criteria
Inclusion
- Diagnosis of open-angle glaucoma and treated for at least 30 days prior to Screening Visit with a topical prostaglandin analog as monotherapy.
- Other protocol-defined inclusion criteria may apply.
Exclusion
- Pregnant, intend to become pregnant, breastfeeding.
- Difference in IOP greater than 3 mm Hg between eyes at Screening Visit.
- Any form of glaucoma other than open-angle glaucoma.
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00643669
Start Date
February 1 2008
Last Update
November 29 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inglewood
Inglewood, California, United States, 90301